aCURRENTLY AVAILABLE MARKERS FOR PROSTATE CANCER 现在可以得到的标志为摄护腺癌 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语翻译 意大利语翻译 荷兰语翻译 瑞典语翻译 希腊语翻译 51La
Thus, new tumor markers for prostate cancer detection, staging, and monitoring are urgently required. In the past few years, considerable attention has been drawn to various ligands, receptors, and binding proteins linked to prostate cancer. Complex PSA is certainly the most promising marker ...
Prostate cancer (PC) is the second leading cause of male cancer death in the United States with an estimated 26,000 deaths in 2016. Two-thirds of all PC deaths observed in the US are men with localized disease who developed metastasis. Several markers for dying from prostate cancer exist, ...
2002. Loss of p53 and c- myc overrepresentation in stage T2-3N1-3M0 prostate cancer are potential markers for cancer progression. Mod Pathol 15:35-44.Qian J, Hirasawa K, Bostwick DG, et al. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) pros- tate cancer ...
Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes a
Prostate Cancer Diagnosis || Blood-Based Tumor Markers for Prostate Cancer Jones,J Stephen 被引量: 0发表: 2013年 Detection of Prostate Cancer With a Blood-Based Assay for Early Prostate Cancer Antigen Prostate-specific antigen lacks specificity for prostate cancer, so the identification and ...
Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. Although this approach leads to a confident diagnosis in most...
Bloodborne markers for prostate cancer have been known for almost 70 years but many have lacked specificity. The development of the prostate-specific antigen (PSA) blood test as a surrogate marker for disease in the 1980s has revolutionized the diagnosis and management of prostate cancer. Level...
Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to
CC Colville,JR Masters,MC Parkinson - Prostate Cancer:Clinical and Scientific Aspects: Bridging the Gap 被引量: 0发表: 2015年 Experimental therapy rationale for prostatic cancer The identification of molecular markers of prostate cancer progression to malignancy has yielded an array of candidate molecul...